FindTrial
Sign In

To see effect of post operative pain relief of drug in unilateral transversus abdominis plane block

An evaluation of dexmedetomidine in usg guided unilateral transversus abdominis plane block - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057163
Enrollment
80
Registered
2023-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K409- Unilateral inguinal hernia, without obstruction or gangrene

Interventions

Intervention1: TAP BLOCK IN UNILATERAL INGUINAL HERNIA: Usg guided TAP block in unilateral inguinal hernia Control Intervention1: dexmedetomidine: Comparison between 0.5mcg/kg and 1 mcg /kg dexmedetom

Sponsors

Gandhi medical college bhopal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Patients of ASA grade - I ,II • Age group 18-60 years of either sex. • All patients scheduled for elective unilateral inguinal hernioplasty under the subarachnoid block (SAB).

Exclusion criteria

Exclusion criteria: Patient refusal or not giving consent. 1 Pregnancy 2 Patient with coagulopathies 3 Seizure disorder 4 ASA grade III and above 5 Coagulopathy 6 Bradycardia and heart block 7 Patient with cardiac diseases 8 Patient on anticoagulants 9 Patient consuming adrenoreceptors agonist or antagonist 10 History of drug allergy to Bupivacaine or dexmedetomidine. 11 Patients with history of cardiac, respiratory, renal or hepatic failure. 12 Psychological disorders.

Design outcomes

Primary

MeasureTime frame
To identify optimal doses of dexmedetomidine between 0.5mcg/kg and 1mcg /kg added to bupivacaine in ultrasound guided transversus abdominis plane block for postoperative analgesia in unilateral inguinal hernioplastyTimepoint: AT 0,2,4,8,12,24 hrs postoperatively—

Secondary

MeasureTime frame
1 To see the level of sedation. 2 To see the time & average dose of rescue analgesics. 3 To see the adverse effects of drugs & technique, if anTimepoint: AT 0,2,4,8,12,24 hrs postoperatively—

Countries

India

Contacts

Public ContactDr. Jyotsna Kubre

Gandhi Medical College, Bhopal

1074vicky@gmail.com9229983164

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026